• Form 4 Keros Therapeutics Inc For: 6 July By Investing.com Investing.com Canada Mon, 06 Jul 2026 20:35:25 GMT
• Keros Therapeutics (KROS) grants director Anne Prener RSUs and stock options Stock Titan Mon, 06 Jul 2026 20:32:04 GMT
• Director Anne Prener files Form 3 insider report at Keros Therapeutics (KROS) Stock Titan Mon, 06 Jul 2026 20:27:04 GMT
• keros therapeutics’ tropos trial termination: what it means for kros investors TipRanks Thu, 02 Jul 2026 16:36:50 GMT
• Behavioral Patterns of KROS and Institutional Flows Stock Traders Daily Tue, 30 Jun 2026 01:10:02 GMT
• KROS Q1 2026 Earnings: Clinical-Stage Biotech Misses EPS Estimates Amid Pipeline Progress - Earnings Acceleration Picks dars.gov.et Mon, 29 Jun 2026 19:33:42 GMT
• Keros Therapeutics, Inc.(NasdaqGM:KROS) added to Russell Microcap Value Benchmark Index marketscreener.com Mon, 29 Jun 2026 13:37:35 GMT
• Keros Therapeutics, Inc.(NasdaqGM: KROS) added to Russell Microcap Index marketscreener.com Mon, 29 Jun 2026 05:38:41 GMT
• nurix therapeutics (nrix) soars 16.4%: is further upside left in the stock? MSN Sun, 28 Jun 2026 09:10:05 GMT
• Keros Therapeutics, Inc.(NasdaqGM: KROS) added to Russell 2000 Value-Defensive Index marketscreener.com Sun, 28 Jun 2026 07:00:00 GMT
• nurix therapeutics (nrix) soars 16.4%: is further upside left in the stock? MSN Sat, 27 Jun 2026 17:39:01 GMT
• keros therapeutics appoints anne prener to its board to boost clinical and strategic growth. Pluang Fri, 26 Jun 2026 00:23:56 GMT
• enterprise value to ebitda forward of keros therapeutics, inc. – nasdaq:kros TradingView Thu, 25 Jun 2026 22:35:12 GMT
• Enterprise value to EBIT forward of Keros Therapeutics, Inc. – NASDAQ:KROS TradingView Thu, 25 Jun 2026 20:50:57 GMT
• price to sales forward of keros therapeutics, inc. – nasdaq:kros TradingView Thu, 25 Jun 2026 20:47:22 GMT
• Keros Therapeutics Appoints Anne Prener to its Board of Directors GlobeNewswire Thu, 25 Jun 2026 20:01:00 GMT
• Keros Therapeutics appoints Anne Prener to board of directors Investing.com Thu, 25 Jun 2026 07:00:00 GMT
• Anne Prener joins Keros Therapeutics (Nasdaq: KROS) board with equity package Stock Titan Thu, 25 Jun 2026 07:00:00 GMT
• keros therapeutics inc (kros) technical analysis: support, resistance, indicators & moving averages TradingKey Tue, 23 Jun 2026 07:00:00 GMT
• keros therapeutics inc (kros) valuation: pe, pb & fair value analysis TradingKey Tue, 23 Jun 2026 07:00:00 GMT
• keros therapeutics inc (kros) risk assessment: volatility, financial risk & investment risk TradingKey Mon, 22 Jun 2026 07:00:00 GMT
• keros therapeutics director nima sells $28,166 in company stock Investing.com UK Fri, 19 Jun 2026 15:37:09 GMT
• keros therapeutics inc (kros) valuation: pe, pb & fair value analysis TradingKey Fri, 19 Jun 2026 01:56:56 GMT
• (kros) movement within algorithmic entry frameworks Stock Traders Daily Thu, 18 Jun 2026 23:58:01 GMT
• keros therapeutics inc (kros) risk assessment: volatility, financial risk & investment risk TradingKey Thu, 18 Jun 2026 10:56:43 GMT
• keros therapeutics inc (kros) financial health: profitability & balance sheet analysis TradingKey Thu, 18 Jun 2026 08:52:22 GMT
• Madison Avenue Partners LP Reduces Stock Holdings in Keros Therapeutics, Inc. $KROS MarketBeat Thu, 18 Jun 2026 07:00:00 GMT
• keros therapeutics inc (kros) technical analysis: support, resistance, indicators & moving averages TradingKey Thu, 18 Jun 2026 06:55:13 GMT
• keros therapeutics inc (kros) earnings forecast: future eps & revenue growth estimates TradingKey Thu, 18 Jun 2026 06:55:11 GMT
• Insider Buying: Jean Bienaime Acquires Additional Shares of Keros Therapeutics Inc (KROS) GuruFocus Wed, 17 Jun 2026 23:09:19 GMT
• keros therapeutics inc (kros) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Wed, 17 Jun 2026 21:31:31 GMT
• keros therapeutics inc (kros) shareholder structure: major shareholders & institutional holdings TradingKey Wed, 17 Jun 2026 21:26:59 GMT
• keros therapeutics inc (kros) dividends & stock splits: historical payouts and event timeline TradingKey Wed, 17 Jun 2026 20:55:00 GMT
• Keros Therapeutics (NASDAQ: KROS) director buys 1,000 shares under 10b5-1 plan Stock Titan Wed, 17 Jun 2026 07:00:00 GMT
• Insider Sell: Charles Newton Sells Shares of Keros Therapeutics Inc (KROS) GuruFocus Tue, 16 Jun 2026 02:40:59 GMT
• keros therapeutics director charles w. newton sells $5,521 in shares Investing.com Tue, 16 Jun 2026 01:02:55 GMT
• insider sell: charles newton sells shares of keros therapeutics inc (kros) GuruFocus Mon, 15 Jun 2026 22:28:32 GMT
• keros therapeutics director charles w. newton sells $5,521 in shares by investing.com Investing.com South Africa Mon, 15 Jun 2026 20:56:07 GMT
• Keros Therapeutics (KROS) director Newton sells 550 shares in planned trade Stock Titan Mon, 15 Jun 2026 07:00:00 GMT
• keros therapeutics, inc. stock 12‑month price target cut to $20.2, implies 99% upside TradingView Sat, 13 Jun 2026 05:20:00 GMT
• keros therapeutics hits 52-week low at $9.69 amidst major decline MarketsMojo Sat, 13 Jun 2026 02:31:50 GMT
• Keros Therapeutics, Inc. Stock 12‑Month Price Target Cut to $20.2, Implies 99% Upside TradingView Fri, 12 Jun 2026 07:00:00 GMT
• kros: ker-065 targets muscle regeneration in dmd, with strong early data and a solid financial runway TradingView Mon, 08 Jun 2026 20:59:50 GMT
• bofa securities maintains keros therapeutics(kros.us) with hold rating, maintains target price $20 富途牛牛 Mon, 08 Jun 2026 13:50:31 GMT
• Keros Therapeutics director Nima sells $28,166 in company stock Investing.com Mon, 08 Jun 2026 07:00:00 GMT
• Director at Keros Therapeutics (NASDAQ: KROS) logs 2,625-share sale Stock Titan Mon, 08 Jun 2026 07:00:00 GMT
• Director at Keros Therapeutics (KROS) sells 2,625 shares in Rule 10b5-1 trade Stock Titan Mon, 08 Jun 2026 07:00:00 GMT
• how (kros) movements inform risk allocation models Stock Traders Daily Sun, 07 Jun 2026 22:28:03 GMT
• insider sell: alpna seth sells shares of keros therapeutics inc (kros) GuruFocus Fri, 05 Jun 2026 22:25:30 GMT
• keros therapeutics (kros) director sells 2,625 shares under rule 10b5-1 plan Stock Titan Fri, 05 Jun 2026 20:15:31 GMT
• keros therapeutics (kros) grants rsus and stock options to director Stock Titan Fri, 05 Jun 2026 20:15:20 GMT
• keros therapeutics (kros) director awarded rsus and stock options Stock Titan Fri, 05 Jun 2026 20:15:12 GMT
• keros therapeutics (nasdaq: kros) director receives rsus and options grant Stock Titan Fri, 05 Jun 2026 07:00:00 GMT
• keros therapeutics director granted rsus and options | kros insider trading Stock Titan Fri, 05 Jun 2026 07:00:00 GMT
• keros therapeutics (nasdaq: kros) backs directors, auditor and pay Stock Titan Wed, 03 Jun 2026 20:01:21 GMT
• Keros Therapeutics, Inc. Stock 12‑Month Price Target Cut to $21.83, Implies 107% Upside TradingView Wed, 03 Jun 2026 07:00:00 GMT
• bofa securities maintains keros therapeutics(kros.us) with hold rating, maintains target price $20 Moomoo Wed, 03 Jun 2026 07:00:00 GMT
• keros therapeutics ceo to present at goldman sachs conference The Globe and Mail Tue, 02 Jun 2026 07:00:00 GMT
• Wedbush Maintains Keros Therapeutics(KROS.US) With Hold Rating, Maintains Target Price $16 富途牛牛 Mon, 01 Jun 2026 14:10:07 GMT
• Keros Therapeutics Announces Participation at Goldman Sachs 47th Annual Global Healthcare Conference GlobeNewswire Mon, 01 Jun 2026 07:00:00 GMT
• keros therapeutics ceo to speak at goldman sachs health conference Stock Titan Mon, 01 Jun 2026 07:00:00 GMT
• keros therapeutics (nasdaq: kros) ceo to join goldman sachs healthcare fireside chat Stock Titan Mon, 01 Jun 2026 07:00:00 GMT
• Keros Therapeutics (KROS) Edges Lower Near Key Support Zone - RVOL Spike dars.gov.et Fri, 29 May 2026 07:00:00 GMT
• duchenne muscular dystrophy clinical trial pipeline: delveinsight highlights major advances, transformative therapies, and 75+ lea... The Manila Times Tue, 26 May 2026 17:11:48 GMT
• Should You Buy KROS After Q1 Miss and Takeda Deal Reset? Yahoo Finance Fri, 22 May 2026 07:00:00 GMT
• KROS Stock Guide to Rinvatercept in DMD and ALS for 2026 Yahoo Finance Fri, 22 May 2026 07:00:00 GMT
• keros therapeutics, inc. (kros) reports q1 loss, misses revenue estimates MSN Thu, 21 May 2026 17:14:36 GMT
• lexington, ma biotech pushes dmd phase 2 start to 3q26 on regulatory hurdles Streetwise Reports Thu, 21 May 2026 09:06:26 GMT
• lexington, ma biopharma co. reports q1 2026 financials, makes r&d plans Streetwise Reports Thu, 21 May 2026 09:06:26 GMT
• lexington, ma biotech pushes dmd phase 2 start to 3q26 on regulatory hurdles Streetwise Reports Wed, 20 May 2026 07:00:00 GMT
• wedbush maintains keros therapeutics(kros.us) with hold rating, maintains target price $16 Moomoo Wed, 20 May 2026 05:47:59 GMT
• hold rating reiterated on keros as takeda partnership progress offsets rinvatercept delays; $16 price target maintained TipRanks Tue, 19 May 2026 21:58:05 GMT
• director at keros therapeutics (kros) buys 1,000 shares under 10b5-1 plan Stock Titan Tue, 19 May 2026 07:00:00 GMT
• wedbush maintains keros therapeutics(kros.us) with hold rating, maintains target price $16 富途牛牛 Tue, 19 May 2026 07:00:00 GMT
• why is keros therapeutics (kros) up 2.5% since last earnings report? MSN Tue, 19 May 2026 01:11:16 GMT
• keros therapeutics, inc. - common stock (nq: kros The Chronicle-Journal Mon, 18 May 2026 16:12:13 GMT
• how much upside is left in keros therapeutics (kros)? wall street analysts think 34.24% MSN Sun, 17 May 2026 07:10:26 GMT
• Earnings Release: Here's Why Analysts Cut Their Keros Therapeutics, Inc. (NASDAQ:KROS) Price Target To US$21.20 Yahoo Finance Sun, 17 May 2026 07:00:00 GMT
• keros therapeutics, inc. (kros) reports q1 loss, misses revenue estimates MSN Sun, 17 May 2026 06:32:06 GMT
• truist financial maintains keros therapeutics(kros.us) with buy rating Moomoo Sat, 16 May 2026 06:32:13 GMT
• keros therapeutics: buy rating reaffirmed on rinvatercept-focused strategy and unchanged $20 price target TipRanks Fri, 15 May 2026 11:25:58 GMT
• how much upside is left in keros therapeutics (kros)? wall street analysts think 34.24% MSN Fri, 15 May 2026 09:08:09 GMT
• Keros Q1 Loss Wider Than Expected, Revenues Plunge Year Over Year Yahoo Finance Fri, 15 May 2026 07:00:00 GMT
• a quick look at today's ratings for keros therapeutics(kros.us), with a forecast between $20 to $20 Moomoo Fri, 15 May 2026 07:00:00 GMT
• nantahala's 1.36m-share stake in keros therapeutics (nasdaq: kros) Stock Titan Fri, 15 May 2026 07:00:00 GMT
• truist financial maintains keros therapeutics(kros.us) with buy rating 富途牛牛 Fri, 15 May 2026 07:00:00 GMT
• why is keros therapeutics (kros) up 2.5% since last earnings report? MSN Thu, 14 May 2026 22:54:50 GMT
• keros therapeutics reports q1 2026 financial results: net loss, cash position, and r&d updates minichart.com.sg Thu, 14 May 2026 15:47:00 GMT
• cellectar biosciences q1 2026: loss narrows 29.6% to -$1.33/share AlphaStreet Thu, 14 May 2026 13:57:21 GMT
• keros therapeutics 1q 2026: revenue $367k, eps ($1.21) — 10-q summary TradingView Thu, 14 May 2026 12:11:01 GMT
• Keros Therapeutics, Inc. (KROS) Reports Q1 Loss, Misses Revenue Estimates Yahoo Finance Thu, 14 May 2026 07:00:00 GMT
• Keros Therapeutics Reports Recent First Quarter 2026 Financial Results GlobeNewswire Thu, 14 May 2026 07:00:00 GMT
• Takeda to advance Keros anemia drug to Phase 3 as Q1 swings to $23.7M loss Stock Titan Thu, 14 May 2026 07:00:00 GMT
• KROS Financials: Income Statement, Balance Sheet & Cash Flow Stock Titan Thu, 14 May 2026 07:00:00 GMT
• Keros Therapeutics (KROS) Revenue Collapse To US$0.4 Million Challenges Bullish Growth Narratives simplywall.st Thu, 14 May 2026 07:00:00 GMT
• keros therapeutics reports q1 2026 loss of $23.7m, revenue $0.4m; cash $281.5m TradingView Thu, 14 May 2026 07:00:00 GMT
• keros (nasdaq: kros) swings to q1 2026 loss as takeda license boost fades Stock Titan Thu, 14 May 2026 07:00:00 GMT
• keros therapeutics (kros) swings to q1 2026 loss as takeda revenue steps down Stock Titan Thu, 14 May 2026 07:00:00 GMT
• (kros) and the role of price-sensitive allocations Stock Traders Daily Tue, 05 May 2026 19:04:02 GMT
• keros therapeutics, inc. (nasdaq:kros) given average rating of "hold" by analysts MarketBeat Sat, 02 May 2026 07:00:00 GMT
• keros therapeutics (kros) stock: technical risk signals | q4 2025: eps misses views - margin compression risk Město Břeclav Wed, 29 Apr 2026 07:00:00 GMT
• sarcopenia market insights highlight expanding outlook till 2034, delveinsight evaluates | tnf pharma, lipocine, biophytis, immuno... Barchart.com Wed, 29 Apr 2026 07:00:00 GMT
• keros therapeutics (kros) to release quarterly earnings on tuesday MarketBeat Tue, 28 Apr 2026 07:00:00 GMT
• adar1 capital management urges keros therapeutics for board change MSN Mon, 27 Apr 2026 15:26:43 GMT
• keros gains orphan drug designation for duchenne muscular dystrophy asset MSN Mon, 27 Apr 2026 14:46:27 GMT
• adar1 capital management urges keros therapeutics for board change MSN Sun, 26 Apr 2026 17:30:31 GMT
• keros gains orphan drug designation for duchenne muscular dystrophy asset MSN Sun, 26 Apr 2026 00:05:34 GMT
• keros gains orphan drug designation for duchenne muscular dystrophy asset MSN Sat, 25 Apr 2026 20:24:06 GMT
• keros gains orphan drug designation for duchenne muscular dystrophy asset MSN Fri, 24 Apr 2026 16:04:46 GMT
• keros therapeutics commences tender offer to repurchase up to $194.4 million shares MSN Fri, 24 Apr 2026 11:22:05 GMT
• adar1 capital management urges keros therapeutics for board change MSN Thu, 23 Apr 2026 20:45:30 GMT
• why is keros therapeutics (kros) up 2.5% since last earnings report? MSN Thu, 23 Apr 2026 20:28:17 GMT
• keros therapeutics (kros) business update | q4 2025: earnings underperform - shared buy zones Cổng thông tin điện tử tỉnh Lào Cai Thu, 23 Apr 2026 04:29:53 GMT
• keros therapeutics (kros) business update | q4 2025: earnings underperform - shared buy zones Cổng thông tin điện tử tỉnh Lào Cai Wed, 22 Apr 2026 22:19:16 GMT
• kros sec filings - keros therapeutics, inc. 10-k, 10-q, 8-k forms Stock Titan Wed, 22 Apr 2026 13:20:36 GMT
• adar1 capital management urges keros therapeutics for board change MSN Wed, 22 Apr 2026 12:39:35 GMT
• keros therapeutics (nasdaq: kros) focuses on rinvatercept and completes $375m capital return Stock Titan Wed, 22 Apr 2026 07:00:00 GMT
• kros financials: income statement, balance sheet & cash flow Stock Titan Wed, 22 Apr 2026 07:00:00 GMT
• why is keros therapeutics (kros) up 2.5% since last earnings report? MSN Tue, 21 Apr 2026 18:34:12 GMT
• why is keros therapeutics (kros) up 2.5% since last earnings report? MSN Mon, 20 Apr 2026 13:41:48 GMT
• KROS Stock: Does the Takeda Deal Lower Dilution Risk in 2026? TradingView Mon, 20 Apr 2026 07:00:00 GMT
• KROS Rinvatercept: What to Know Before DMD Phase II Starts Yahoo Finance Mon, 20 Apr 2026 07:00:00 GMT
• kros 2026 watchlist: 3 catalysts that could reset sentiment Yahoo Finance Mon, 20 Apr 2026 07:00:00 GMT
• keros therapeutics (kros) stock: growth vs risks (momentum fading) 2026-04-20 - wyckoff distribution The Legal Advocate Mon, 20 Apr 2026 07:00:00 GMT
• bienaime buys keros therapeutics (kros) shares worth $11,700 by investing.com Investing.com India Sat, 18 Apr 2026 07:00:00 GMT
• insider buying: jean bienaime acquires additional shares of keros therapeutics inc (kros) GuruFocus Sat, 18 Apr 2026 00:45:00 GMT
Keros Therapeutics, Inc(NASDAQ:KROS) 
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, wh...
Website: http://www.kerostx.com
Founded: 2015
Full Time Employees: 32
CEO: Jasbir S. Seehra
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends